AMCP Nexus 2026: Insights shaping market access strategy

From real-world analysis of payer engagement with pre-approval information exchange to research on direct-to-patient anti-obesity medication models and the evolving biosimilar landscape, Cencora shared timely perspectives on some of the most important issues shaping market access today. 

Explore expert Q&As and related poster content highlighting how payers are evaluating evidence earlier, responding to new access and distribution models, and preparing for continued change across the healthcare landscape.